Schedule 13G ownership disclosure

Vera Therapeutics Inc

Security class unavailable · CUSIP: 92337R101

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,409,098
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-23-001012
Form type
SC 13G
Filer
Kynam Capital Management, LP
CIK
CIK 1907884
Filed
Feb 10, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub